Mairs and Power's TECH Position Overview
Mairs and Power (via Mairs & Power INC) currently holds 1.27 M shares of Bio-Techne Corporation (TECH) worth $92.3 M, representing 0.85% of the portfolio. First purchased in 2014-Q3, this long-term strategic position has been held for 49 quarters.
Based on 13F filings since 2013, Mairs and Power has maintained a long-term strategic position in TECH, representing a significant commitment to this investment thesis. Largest addition occurred in Q4 2014, adding 821,592 shares. Largest reduction occurred in Q3 2026, reducing 1.43 M shares.
Analysis based on 13F filings available since 2013 Q2
Mairs and Power's Bio-Techne Corporation (TECH) Holding Value Over Time
Track share changes against reported price movement
Quarterly Bio-Techne Corporation (TECH) Trades by Mairs and Power
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q3 2026 | -1.43 M | Reduce 52.84% | 1.27 M | $72.47 |
| Q2 2026 | -49,584 | Reduce 1.80% | 2.7 M | $70.65 |
| Q1 2026 | -17,257 | Reduce 0.62% | 2.75 M | $52.26 |
| Q4 2025 | -39,870 | Reduce 1.42% | 2.77 M | $58.81 |
| Q3 2025 | +91,031 | Add 3.35% | 2.81 M | $55.63 |
| Q2 2025 | +64,585 | Add 2.44% | 2.72 M | $51.45 |
| Q1 2025 | -21,975 | Reduce 0.82% | 2.65 M | $58.63 |
| Q4 2024 | -23,028 | Reduce 0.85% | 2.67 M | $72.03 |
| Q3 2024 | -43,596 | Reduce 1.59% | 2.7 M | $79.93 |
| Q2 2024 | -218,965 | Reduce 7.40% | 2.74 M | $71.65 |
| Q1 2024 | -120,126 | Reduce 3.90% | 2.96 M | $70.39 |
| Q4 2023 | +25,903 | Add 0.85% | 3.08 M | $77.16 |
| Q3 2023 | -6,058 | Reduce 0.20% | 3.05 M | $68.07 |
| Q2 2023 | +33,660 | Add 1.11% | 3.06 M | $81.63 |
| Q1 2023 | +214,948 | Add 7.65% | 3.03 M | $74.19 |
| Q4 2022 | +116,550 | Add 4.33% | 2.81 M | $82.88 |
| Q3 2022 | +70,760 | Add 2.70% | 2.69 M | $71.00 |
| Q2 2022 | -8,128 | Reduce 0.31% | 2.62 M | $86.66 |
| Q1 2022 | +16,588 | Add 0.63% | 2.63 M | $108.26 |
| Q4 2021 | -35,276 | Reduce 1.33% | 2.62 M | $129.33 |
| Q3 2021 | -264,808 | Reduce 9.08% | 2.65 M | $121.14 |
| Q2 2021 | -164,796 | Reduce 5.35% | 2.92 M | $112.57 |
| Q1 2021 | -312,184 | Reduce 9.20% | 3.08 M | $95.48 |
| Q4 2020 | -29,208 | Reduce 0.85% | 3.39 M | $79.39 |
| Q3 2020 | -186,300 | Reduce 5.16% | 3.42 M | $61.93 |
| Q2 2020 | -487,964 | Reduce 11.91% | 3.61 M | $66.02 |
| Q1 2020 | +83,988 | Add 2.09% | 4.1 M | $47.40 |
| Q4 2019 | -149,372 | Reduce 3.59% | 4.01 M | $54.88 |
| Q3 2019 | -111,404 | Reduce 2.61% | 4.16 M | $48.92 |
| Q2 2019 | -342,416 | Reduce 7.42% | 4.27 M | $52.12 |
| Q1 2019 | -146,448 | Reduce 3.08% | 4.62 M | $49.64 |
| Q4 2018 | +77,948 | Add 1.66% | 4.76 M | $36.18 |
| Q3 2018 | -483,208 | Reduce 9.35% | 4.68 M | $51.03 |
| Q2 2018 | -346,680 | Reduce 6.29% | 5.17 M | $36.99 |
| Q1 2018 | -224,840 | Reduce 3.92% | 5.51 M | $37.76 |
| Q4 2017 | -39,692 | Reduce 0.69% | 5.74 M | $32.39 |
| Q3 2017 | -18,028 | Reduce 0.31% | 5.78 M | $30.22 |
| Q2 2017 | +236,548 | Add 4.25% | 5.8 M | $29.38 |
| Q1 2017 | +84,800 | Add 1.55% | 5.56 M | $25.41 |
| Q4 2016 | +6,204 | Add 0.11% | 5.47 M | $25.71 |
| Q3 2016 | +63,340 | Add 1.17% | 5.47 M | $27.37 |
| Q2 2016 | +162,760 | Add 3.10% | 5.41 M | $28.19 |
| Q1 2016 | +14,756 | Add 0.28% | 5.24 M | $23.63 |
| Q4 2015 | +53,444 | Add 1.03% | 5.23 M | $22.50 |
| Q3 2015 | -335,672 | Reduce 6.09% | 5.17 M | $23.11 |
| Q2 2015 | -8,980 | Reduce 0.16% | 5.51 M | $24.62 |
| Q1 2015 | +337,068 | Add 6.50% | 5.52 M | $25.07 |
| Q4 2014 | +821,592 | Add 18.84% | 5.18 M | $23.10 |
| Q3 2014 | +4.36 M | New Buy | 4.36 M | $23.39 |
Mairs and Power's Bio-Techne Corporation Investment FAQs
Mairs and Power first purchased Bio-Techne Corporation (TECH) in Q3 2014, acquiring 4,360,088 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Mairs and Power has held Bio-Techne Corporation (TECH) for 49 quarters since Q3 2014.
Mairs and Power's largest addition to Bio-Techne Corporation (TECH) was in Q3 2014, adding 4,360,088 shares worth $101.97 M.
According to the latest 13F filing for Q3 2026, Mairs and Power's firm, Mairs & Power INC, owns 1,273,645 shares of Bio-Techne Corporation (TECH), valued at approximately $92.3 M.
As of the Q3 2026 filing, Bio-Techne Corporation (TECH) represents approximately 0.85% of Mairs and Power's publicly disclosed stock portfolio, making it one of their key holdings.
Mairs and Power's peak holding in Bio-Techne Corporation (TECH) was 5,795,948 shares, as reported at the end of Q2 2017.